A large retrospective study of weight changes associated with different HIV drugs in the international CASCADE cohort of people in very early infection, has been published in Lancet HIV together with an editorial on this complication of modern HIV therapy.
The study is important for looking at the impact of ART that has been initiated soon after HIV infection and in people who were using treatment for the first time. Looking into this time period minimises the impact of residual confounding from both potential metabolic complications related to chronic HIV and the potential impact of previous ART. The results contribute important data to one of the least explained issues experienced by many people living with HIV.
Read the full study report at HIV i-Base.
Source : HIV i-Base
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.